Literature DB >> 18269640

The influence of age and body mass index on the metabolic syndrome and its components.

C M Alexander1, P B Landsman, S M Grundy.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the influence of ageing and body mass index (BMI) on the revised National Cholesterol Education Program (NCEP)-defined metabolic syndrome, its components, diabetes and coronary heart disease prevalence using the Third National Health and Nutrition Examination Survey.
METHODS: Data from adults aged 20 and older who received morning physical examinations after a fast of at least 9 h (n = 7959), representing 196.8 million Americans were used in this analysis. The population was stratified by age deciles and BMI categories using standard definitions of overweight and obesity. Due to small sample size, those few individuals with BMI <18.5 were excluded.
RESULTS: Fasting glucose, diabetes and systolic blood pressure (SBP) seem to have a linear relationship with age and BMI, that is, increasing BMI seems to linearly reduce the age decile when the mean exceeds the NCEP cutpoint. Regardless of BMI, the prevalence of diabetes and hypertension increases with age. Triglyceride levels and prevalence of metabolic syndrome follow a pattern that is less linear. Fasting insulin and C-reactive protein (CRP) levels correlate better with BMI than age. Diastolic BP and HDL cholesterol for men and women (analysed separately) did not correlate with either age or BMI.
CONCLUSION: For each component of the metabolic syndrome and associated factors, there is a complex interaction between ageing and obesity. Some components are associated with obesity but not ageing (e.g. CRP), while others are associated with both obesity and ageing (e.g. glucose). Even when the association exists, the specific relationship can appear to be more (e.g. SBP) or less (e.g. triglycerides) linear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269640     DOI: 10.1111/j.1463-1326.2006.00695.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  30 in total

1.  Overweight adults may have the lowest mortality--do they have the best health?

Authors:  Anna Zajacova; Jennifer Beam Dowd; Sarah A Burgard
Journal:  Am J Epidemiol       Date:  2011-01-12       Impact factor: 4.897

2.  Body mass index in a large cohort of patients assigned to age decades between <20 and ≥80 years: relationship with cardiovascular morbidity and medication.

Authors:  A Dzien; H Winner; E Theurl; C Dzien-Bischinger; M Lechleitner
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  The genetics of obesity and the metabolic syndrome.

Authors:  Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

4.  Leukocyte Count versus C-Reactive Protein Levels in Obese Portuguese Patients Aged 6-12 Years Old.

Authors:  Henrique Nascimento; Susana Rocha; Carla Rego; Helena Ferreira Mansilha; Alexandre Quintanilha; Alice Santos-Silva; Luís Belo
Journal:  Open Biochem J       Date:  2010-06-10

5.  Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction.

Authors:  Wassef Karrowni; Yan Li; Philip G Jones; Sharon Cresci; Mouin S Abdallah; David E Lanfear; Thomas M Maddox; Darren K McGuire; John A Spertus; Phillip A Horwitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-18       Impact factor: 8.311

6.  Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.

Authors:  James C Barton; J Clayborn Barton; Paul C Adams; Ronald T Acton
Journal:  Metab Syndr Relat Disord       Date:  2016-01-15       Impact factor: 1.894

7.  Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis.

Authors:  Walter Ageno; Matteo N D Di Minno; Cihan Ay; Moon Ju Jang; John-Bjarne Hansen; Lyn M Steffen; Amparo Vayà; Marcello Rattazzi; Ingrid Pabinger; Doyeun Oh; Giovanni Di Minno; Sigrid K Braekkan; Mary Cushman; Elena Bonet; Paolo Pauletto; Alessandro Squizzato; Francesco Dentali
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-11       Impact factor: 8.311

8.  Metabolic syndrome and insulin resistance in Division 1 collegiate football players.

Authors:  James R Borchers; Kelley L Clem; Diane L Habash; Haikady N Nagaraja; Lisa M Stokley; Thomas M Best
Journal:  Med Sci Sports Exerc       Date:  2009-12       Impact factor: 5.411

9.  Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Holly John; Karen M J Douglas; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-16       Impact factor: 5.156

10.  Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters.

Authors:  Purneshwar Kumar Pandey; Abhijit Swami; Tanuj Kumar Biswas; Riturag Thakuria
Journal:  Arch Rheumatol       Date:  2016-10-13       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.